A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
Journal Information
Full Title: J Infect Dis
Abbreviation: J Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Communicable Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Potential conflicts of interest. S. R., N. K., P. L., M. W. P., L. B., A. S. A., W. C. G., K. U. J., S. P. L., and C. W. are current or former employees of Pfizer Inc and may hold stock and/or stock options. J. P. received support from Pfizer as a study investigator.: All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed."
"Financial support . This work was supported by Pfizer Inc. Funding to pay the Open Access publication charges for this article was provided by Pfizer Inc. Financial support"
"Clinical Trials Registration. ClinicalTrials.gov NCT02561195."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025